Rani Therapeutics RANI
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 1.35 | 97.80 | 0.05 | -8,535 | -10 | |
| 2025Q3 | 0.50 | 100.95 | -0.10 | -7,257 | -5 | |
| 2025Q2 | 0.51 | 101.52 | -0.18 | -10,505 | -7 | |
| 2025Q1 | 1.26 | 101.85 | -0.22 | -12,013 | -7 | |
| 2024Q4 | 1.37 | 102.47 | -0.27 | -14,958 | -9 | |
| 2024Q3 | 2.16 | 103.65 | -0.23 | -11,799 | -7 | |
| 2024Q2 | 3.80 | 103.63 | -0.26 | -12,523 | -7 | |
| 2024Q1 | 3.11 | 104.07 | -0.29 | -14,034 | -7 | |
| 2023Q4 | 3.32 | 105.29 | -0.27 | -13,434 | -7 | |
| 2023Q3 | 2.18 | 104.93 | -0.36 | -17,855 | -9 | |
| 2023Q2 | 4.12 | 105.15 | -0.37 | -18,294 | -9 | |
| 2023Q1 | 5.16 | 105.70 | -0.33 | -16,516 | -8 | |
| 2022Q4 | 5.90 | 104.91 | -0.35 | -17,482 | -9 | |
| 2022Q3 | 9.58 | 102.38 | -0.33 | -16,342 | -8 | |
| 2022Q2 | 10.33 | 100.22 | -0.31 | -15,847 | -8 | |
| 2022Q1 | 13.50 | 100.11 | -0.29 | -13,780 | -6 | |
| 2021Q4 | 16.35 | 100.12 | -0.27 | -13,362 | -5 | |
| 2021Q3 | 17.82 | 97.30 | -0.16 | -27,781 | -3 | |
| 2021Q2 | -0.29 | -5,258 | -5 | |||
| 2021Q1 | -0.30 | -5,198 | -6 |